feed,title,long_url,short_url
RS,Coronavirus Disease 2019 Rebound in Nirmatrelvir Plus Ritonavir Treatment and Control Groups: A Prospective Cohort Study,https://www.researchsquare.com/article/rs-5368863/latest,https://da.gd/iDYEv
